cardiology

Pediatric chest pain and syncope: Know when to referWhat causes chest pain and syncope in children and adolescents, and how can pediatricians recognize and eliminate the causes that may lead to significant morbidity or even death?
Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.
Pediatric hypertensionHypertension in children is not just a specialty problem. It's much more common in general pediatrics than community pediatricians might realize.
How physicians can prepare for the new ICD-10 codesNew ICD-10 procedure and diagnosis codes—added as a result of the thawing of a partial code freeze in effect since 2011—are coming October 1.
Zika screening: Is looking for microcephaly enough?A look at Brazilian Zika virus cases indicates that looking for just microcephaly may cause doctors to miss cases of congenital Zika virus infection. Plus: Why do women fare worse following cardiac arrest than their male counterparts?
How Express Scripts will manage pricey cholesterol drugsAfter much criticism on the price of 2 new cholesterol-lowering drugs, Praluent and Repatha, Express Scripts said this week it will now include both drugs in its National Preferred Formulary.
AUA updates testosterone therapy position statementThe AUA has released an updated version of its position statement on testosterone therapy.
Hypertension in an infant girlA previously healthy 8-month-old girl presented to the emergency department with fever and increased work of breathing. She was hospitalized for hypoxia attributed to community-acquired pneumonia, treated with ceftriaxone, and weaned to room air over several days. On the morning of planned discharge, she was noted to have had persistently elevated blood pressures for the past 12 hours.
FDA approves major cholesterol drugThe FDA on August 27 approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.
6 reasons cholesterol drug guidelines must changeIn a commentary published in the Journal of the American Medical Association, experts from CVS Health Research Institute encouraged the review of current treatments for high cholesterol.